 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
SECOND REGULAR SESSION-2020
Legislative Document No. 2116
H.P. 1510 House of  Representatives, February 25, 2020
An Act  To Improve  Prescription Information Access
(AFTER  DEADLINE)
Approved for  introduction by a majority  of the Legislative Council  pursuant to Joint Rule 
205.
Reference to the Committee on Health  Coverage, Insurance and Financial Services 
suggested and ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative CRAVEN of Lewiston.
Cosponsored by Senator SANBORN, L. of Cumberland and
Representatives: AUSTIN of Skowhegan, COOPER of Yarmouth, CUDDY of Winterport, DOORE of  Augusta, MEYER of Eliot,  SHEATS  of Auburn, STOVER of Boothbay, Senator: 
CHENETTE of York.

Page 1 - 129LR3155(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  32 MRSA §13794, first ¶, as amended by PL 2019, c. 34, §5, is further 
3amended to read:
4Every drug dispensed pursuant to prescription, whether for a legend drug or not, must 
5carry on the label the following information:  the prescription number; the date of filling; 
6the patient's name; directions for use; the name and strength of the drug and the amount 
7dispensed, including either the brand name of the drug or, if a generic and therapeutically 
8equivalent drug or interchangeable biological product is dispensed the label must be, 
9information in accordance with section 13781; the beyond use date of the drug; the name 
10of the practitioner prescribing the drug; and the name, address and telephone number of 
11the pharmacy where the prescription was compounded and dispensed; and a barcode that 
12allows the patient to digitally access the information on the label.  For purposes of this 
13section, "barcode" means a 2-dimensional machine-scannable barcode that can be read by 
14a camera in a mobile device, such as a smartphone, and is used for storing information or 
15directing or leading a user to additional information.  For purposes of this section, 
16"beyond use date" means a date beyond which the contents of the prescription are not 
17recommended to be used.
18Sec. 2.  Maine Board of Pharmacy rulemaking.  By January 1, 2021, the 
19Department of Professional and Financial Regulation, Maine Board of Pharmacy shall 
20adopt rules to implement the requirement in the Maine Revised Statutes, Title 32, section 
2113794 that a barcode that allows a patient to digitally access prescription information 
22appear on a prescription label.  Rules adopted pursuant to this section are routine 
23technical rules as defined in Title 5, chapter 375, subchapter 2-A.
24SUMMARY
25This bill requires a 2-dimensional machine-scannable barcode that allows a patient to 
26digitally access prescription information to appear on the prescription label.  It also makes 
27a clarifying technical correction.
